Jim Simons Vigil Neuroscience, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 59,964 shares of VIGL stock, worth $223,066. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,964Holding current value
$223,066% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding VIGL
# of Institutions
54Shares Held
26.7MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$21.7 Million2.49% of portfolio
-
Northpond Ventures, LLC4.21MShares$15.7 Million40.32% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.17MShares$8.06 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$6.75 Million0.19% of portfolio
-
Artal Group S.A. Luxembourg, N41.81MShares$6.74 Million0.33% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $105M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...